期刊
COLLOIDS AND SURFACES B-BIOINTERFACES
卷 131, 期 -, 页码 182-190出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.colsurfb.2015.04.055
关键词
Solid lipid nanoparticles; Nanostructured lipid carriers; Oxyresveratrol; Oral absorption
资金
- Thailand Research Fund [BRG 5580004]
- Faculty of Pharmaceutical Sciences, Prince of Songkla University, Thailand
The aim of this study was to develop and assess nanostructured lipid carriers (NLC) compared to solid lipid nanoparticles (SLN) for improving the oral bioavailability of oxyresveratrol (OXY). The OXY formulated as SLN (OXY-SLN) and NLC (OXY-NLC) were prepared by a high shear homogenization technique. The optimized OXY-NLC (NLC3) produced smaller nanoparticle sizes (96 +/- 0.9 nm) than that of the OXY-SLN (108 +/- 0.3 nm) with a homogeneous size distribution and a high zeta potential. The spherical NLC had a significantly higher efficiency for OXY entrapment (89 +/- 0.1%) and a better stability than the SLN after storage for 12 months at 4 +/- 2 degrees C according to parameters such as smaller particles, greater zeta potential and a higher loading capacity (p<0.05). Differential scanning calorimetry (DSC) showed a less ordered crystalline structure of NLC than SLN. The accumulated drug in an amorphous state in the NLC was also confirmed by powder X-ray diffraction (PXRD). The in vitro release profiles of the OXY-NLC showed a more sustained release compared to the SLN and unformulated OXY. The in vivo pharmacokinetic profiles implied enterohepatic recycling of OXY in the Wistar rat. Meanwhile, the oral absorption pattern of OXY was modified by both types of lipid nanoparticles. The SLN and NLC increased the relative bioavailability of OXY to 125% and 177%, respectively, compared with unformulated OXY. These findings indicated that NLC could be used as a potential carrier to improve the oral bioavailability of OXY. (C) 2015 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据